# HIV Vaccine Innovation, Science, and Technology Acceleration in Africa (HIV-VISTA)

Source: https://welltoldgrants.com/grants/7200aa23rfa00002-hiv-vaccine-innovation-science-and-technology-acceleration/  
Official notice: https://www.grants.gov/search-results-detail/344529

> Agency for International Development offered grants of up to $46.0 million (at least $46.0 million) to nonprofits, colleges and universities and businesses. It expected to make about 2 awards. Applications closed on May 31, 2023.

| Field | Value |
|---|---|
| Opportunity number | 7200AA23RFA00002 |
| Agency | Agency for International Development |
| Status | Forecast |
| Deadline | May 31, 2023 |
| Award ceiling | $46.0 million |
| Award floor | $46.0 million |
| Expected awards | 2 |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 98.001 |

## Who can apply

- Public and State controlled institutions of higher education
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Eligibility for this NOFO is restricted to local entities in African countries, using the definition of “local entity” in the PEPFAR 2022 Country and Regional Operational Plan (COP/ROP). Per this guidance, local entity is defined as “an entity other than a sole proprietorship (such as a corporation or not-for-profit) must meet all three areas of eligibility:(1) EITHER, must be incorporated or legally organized under the laws of, and have its principal place of business in, the country or a country in the region served by the PEPFAR program with which the entity is or may become involved; OR must exist in the region where PEPFAR programs are implemented;(2) EITHER, must be at 75% beneficially owned at the time of application by individuals who are citizens or lawfully admitted permanent residents of that same country; OR at least 75% of the entity’s staff (senior, mid-level, support) at the time of application must be citizens or lawfully admitted permanent residents of that same country; (3) Where an entity has a Board of Directors, at least 51% of the members of the Board must also be citizens or lawfully admitted permanent residents of such country.

## What the grant funds

The objective of the HIV-VISTA Project is to support sub-Saharan African scientists, institutions, and innovative systems of collaboration in designing and testing improved HIV vaccine candidates that will advance the field toward the long-term goal of a safe and globally-effective HIV vaccine. Activities should be implemented in at least three different countries in sub-Saharan African Closing Date and Time for CONCEPT NOTE: Friday January 20, 2023; 4:00 PM, Washington DC local time Closing Date and Time for FULL APPLICATION (INVITATION ONLY): Wednesday May 31, 2023; at 4:00 PM, Washington DC local time Note: All Applicants that fit the Eligibility criteria are welcome to submit concept notes. At the concept stage, please submit proof documentation the eligibility. However, request for Full Application will be based on invitation. Therefore in order to be considered, all eligible Applicants interested must submit concept note by deadline to be considered for co-creation and Full Application. Please download and read all the relevant documents especially the NOFO Amendment 2 to understand the process. (UPDDATE APRIL 10, 2023: The process for concept notes has been closed.)

## Questions people ask

### Is 7200AA23RFA00002 still open?

No. It closed on May 31, 2023.

### Who can apply for HIV Vaccine Innovation, Science, and Technology Acceleration in Africa (HIV-VISTA)?

Agency for International Development accepted applications from nonprofits, colleges and universities and businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for HIV Vaccine Innovation, Science, and Technology Acceleration in Africa (HIV-VISTA)?

Closed May 31, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $46.0 million each.

### Who has won USAID Foreign Assistance for Programs Overseas grants before?

The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.